> Main Business Areas
| API's & Intermediates | DMF FDA | DMF JAPAN | CEP EDQM |
| Penicillin G (Pen G) | 13439 | ||
| 6-aminopenicillanic acid (6-APA) | 12348 | ||
| Ampicillin trihydrate Powder (compacted) | 13440 | R1-CEP 2002-178-Rev 01 | |
| Amoxicillin trihydrate Powder (compacted) | 13549 | 218MF10776 | R1-CEP 2001-123-Rev 01 |
| Cephalexin monohydrate Powder (compacted) | 13588 | 220MF10148 | R0-CEP 2003-166-Rev 00 |
| Enzymes |
| Penicillin acylase |
| Under Development | |
| ß lactamase inhibitors | Tazobactam acid and Sulbactam (acid and sterile sodium salt) |
| Semisynthetic ß-lactams (acid and sterile sodium salt) | Piperacillin |
| Nafcillin | |
| Ticarcillin | |
| Oxacillin | |
| Dicloxacillin | |
| Cloxacillin | |
| Flucloxacillin | |
| Cephalosporins | Cefoperazone |
| Carbapenems | Meropenem |
| Doripenem | |
| Ertapenem |



